5 Einträge gefunden

1. Baseline prevalence of erectile dysfunction in a prostate cancer screening population.

   1. Walz, Jochen
   2. Perrotte, Paul
   3. Suardi, Nazareno
   4. Hutterer, Georg
   5. Jeldres, Claudio
   6. Bénard, Francois
   7. Valiquette, Luc

   2008 - Forschungsinformationssystem des UKE
2. Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.

   1. Walz, Jochen
   2. Nazareno, Suardi
   3. Hutterer, Georg C
   4. Perrotte, Paul
   5. Gallina, Andrea
   6. Bénard, Francois
   7. Valiquette, Luc

   2008 - Forschungsinformationssystem des UKE
3. High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.

   1. Jeldres, Claudio
   2. Suardi, Nazareno
   3. Saad, Fred
   4. Montorsi, Francesco
   5. Shariat, Shahrokh F
   6. Perrotte, Paul
   7. Bhojani, Naeem

   2008 - Forschungsinformationssystem des UKE
4. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.

   1. Walz, Jochen
   2. Gallina, Andrea
   3. Saad, Fred
   4. Montorsi, Francesco
   5. Perrotte, Paul
   6. Shariat, Shahrokh F
   7. Jeldres, Claudio

   2007 - Forschungsinformationssystem des UKE
5. Ejaculatory disorders may affect screening for prostate cancer.

   1. Walz, Jochen
   2. Perrotte, Paul
   3. Gallina, Andrea
   4. Bénard, Francois
   5. Valiquette, Luc
   6. McCormack, Michael
   7. Montorsi, Francesco

   2007 - Forschungsinformationssystem des UKE